Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Citi
Fuji
Fish and Richardson
QuintilesIMS
UBS
Federal Trade Commission
Accenture
Farmers Insurance

Generated: January 21, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050141

« Back to Dashboard

NDA 050141 describes BICILLIN L-A, which is a drug marketed by King Pharms Llc and Wyeth Ayerst and is included in two NDAs. It is available from three suppliers. Additional details are available on the BICILLIN L-A profile page.

The generic ingredient in BICILLIN L-A is penicillin g benzathine. There are ninety-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the penicillin g benzathine profile page.
Summary for 050141
Tradename:BICILLIN L-A
Applicant:King Pharms Llc
Ingredient:penicillin g benzathine
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 050141
Medical Subject Heading (MeSH) Categories for 050141
Suppliers and Packaging for NDA: 050141
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BICILLIN L-A penicillin g benzathine INJECTABLE;INJECTION 050141 NDA A-S Medication Solutions 50090-1016 50090-1016-0 10 SYRINGE in 1 PACKAGE (50090-1016-0) > 2 mL in 1 SYRINGE
BICILLIN L-A penicillin g benzathine INJECTABLE;INJECTION 050141 NDA A-S Medication Solutions 50090-1016 50090-1016-1 1 SYRINGE in 1 PACKAGE (50090-1016-1) > 2 mL in 1 SYRINGE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength600,000 UNITS/ML
Approval Date:Approved Prior to Jan 1, 1982TE:BCRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength300,000 UNITS/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Julphar
McKinsey
Moodys
Chubb
Mallinckrodt
Citi
Federal Trade Commission
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.